Betekenis van:
blood agar

Voorbeeldzinnen

1. This agar is described in the CRL-AR website. Based on colony morphology and colour, up to five colonies indicative for being MRSA shall be subcultivated on blood agar.
2. Direct culture of the sample shall be carried out on a selective medium suitable for Campylobacter, (i.e. modified Campylobacter blood free selective medium (CCDA); Karmali; or Preston Agar).
3. have been subjected with negative result to an agar-gel immuno-diffusion test (Coggins test) or an ELISA for equine infectious anaemia carried out on a blood samples taken on … (3), being during the past 30 days prior to the date of the first collection of ova or embryos and the last test was carried out on a sample of blood taken on … (3); being not more than 90 days before the ova and embryos were collected;
4. have been subjected with negative result to an agar gel immunodiffusion test (Coggins test) or an ELISA for equine infectious anaemia carried out on a blood sample taken on … (4), being during the past 30 days prior to the date of the first collection of ova or embryos and the test was last carried out on a sample of blood taken on … (4), being not more than 90 days before the ova or embryos were collected (5);
5. the donor females and the donors of ovaries, oocytes and other tissues used in the production of embryos were subjected to an agar gel immuno diffusion test and a serum neutralisation test for the detection of antibodies against the epizootic haemorrhagic disease virus carried out with negative results on a blood sample taken not less than 21 days following collection (1);
6. or[II.4.10. were resident in the exporting country (5) and were tested on two occasions in an agar gel immunodiffusion test and in a serum neutralisation test for Akabane virus and Aino virus carried out with negative results in an approved laboratory on samples of blood taken not more than 12 months apart prior to and not less than 21 days following collection of the semen;]
7. were resident in the country of export in which the following serotypes of epizootic haemorrhagic disease (EHD) exist: ; and tested negative on two occasions not more than 12 months apart to an agar-gel immuno-diffusion test (4) and a virus neutralisation test for all above-listed serotypes of EHD, carried out in an approved laboratory on samples of blood taken prior to and not less than 21 days following collection of the semen; ***
8. were resident in the country of export in which the following serotypes of epizootic haemorrhagic disease (EHD) exist: ; and tested negative on two occasions not more than 12 months apart to an agar-gel immuno-diffusion test (4) and to a virus neutralisation test for all above-listed serotypes of EHD, carried out in an approved laboratory on samples of blood taken prior to and not less than 21 days following collection of the semen; ***
9. or [II.4.9. were resident in the exporting country (5) and were tested on two occasions in an agar-gel immuno-diffusion test and in a serum neutralisation test for Akabane virus and Aino virus carried out with negative results in an approved laboratory on samples of blood taken not more than 12 months apart prior to and not less than 21 days following collection of the semen;]
10. all equidae comprising the consignment must have undergone an agar gel immunodiffusion test for EIA (‘the AGID test’) carried out with negative results on blood samples taken on two occasions 90 days apart; the second sample of which must have been collected within 10 days prior to the date of dispatch of the consignment from the approved holding; the AGID test must meet the criteria established by the relevant Chapter of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2009 of the World Organisation for Animal Health (OIE) (‘the Manual’);
11. or [II.2.7. were collected/produced (1) in the exporting country (5) in which according to official findings the following serotypes of epizootic haemorrhagic disease (EHD) exist: … and were tested negative on two occasions not more than 12 months apart in an agar gel immunodiffusion test or competitive enzyme-linked immunosorbent assay (6) and a virus neutralisation test for all above listed serotypes of EHD, carried out in approved laboratory on samples of blood taken prior to and not less than 21 days following collection of the ova/embryos (1);]
12. or [II.5.2. were collected in the exporting country (5) in which according to official findings the following serotypes of epizootic haemorrhagic disease (EHD) exist: … and were tested negative on two occasions not more than 12 months apart in an agar-gel immuno-diffusion test or competitive enzyme-linked immunosorbent assay (6) and a virus neutralisation test for all above-listed serotypes of EHD, carried out in approved laboratory on samples of blood taken prior to and not less than 21 days following collection of the ova/embryos (1);]
13. or [II.4.8. were resident in the exporting country (5) in which according to official findings the following serotypes of epizootic haemorrhagic disease (EHD) exist: … and were tested on two occasions in an agar-gel immuno-diffusion test or competitive enzyme-linked immunosorbent assay (6) and in a virus neutralisation test for all above listed serotypes of EHD, carried out with negative results in an approved laboratory on samples of blood taken not more than 12 months apart prior to and not less than 21 days following collection of the semen;]
14. or [II.4.9. were resident in the exporting country (5) in which according to official findings the following serotypes of epizootic haemorrhagic disease (EHD) exist: … and were tested on two occasions in an agar gel immunodiffusion test or competitive enzyme-linked immunosorbent assay (6) and in a virus neutralization test for all above-listed serotypes of EHD, carried out with negative results in an approved laboratory on samples of blood taken not more than 12 months apart prior to and not less than 21 days following collection of the semen;]
15. has not been free from foot-and-mouth disease for the 12 months immediately prior to the collection of the embryos and/or practises vaccination against it and the donor females and the donors of ovaries, oocytes and other tissues used in the production of embryos come from a holding in which no animal has been vaccinated against foot-and-mouth disease during the 30 days prior to collection, and the embryos have been stored in approved conditions for a minimum period of 30 days immediately after collection; 11.2.3. either (1): has been free from bluetongue and epizootic haemorrhagic disease (EHD) for the 12 months immediately prior to collection of the embryos to be exported and does not practise vaccination against them or 11.2.3.2. has not been free from bluetongue and epizootic haemorrhagic disease (EHD) for the 12 months immediately prior to collection of the embryos to be exported and/or practises vaccination against them and the embryos have been stored in approved conditions for a minimum period of 30 days immediately after collection, and the donor females and the donors of ovaries, oocytes and other tissues used in the production of embryos were subjected with negative results to an agar gel immuno diffusion test and a serum neutralisation test for epizootic haemorrhagic disease antibodies on a blood sample taken not less than 21 days following collection.11.3.